Adage Capital Partners
DPLO

Adage Capital Partners’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Adage Capital Partners’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-500,000
Closed -$6.3M – 763
2016
Q4 		$6.3M Buy
500,000
+100,000
+25% +$1.86M 0.02% 587
2016
Q3 		$11.2M Sell
400,000
-300,000
-43% -$10.1M 0.03% 504
2016
Q2 		$24.5M Sell
700,000
-123,972
-15% -$3.9M 0.07% 331
2016
Q1 		$22.6M Sell
823,972
-136,384
-14% -$4.02M 0.06% 341
2015
Q4 		$32.9M Buy
960,356
+48,000
+5% +$1.5M 0.09% 267
2015
Q3 		$26.2M Sell
912,356
-37,644
-4% -$1.61M 0.07% 323
2015
Q2 		$42.5M Sell
950,000
-379,800
-29% -$14.3M 0.11% 237
2015
Q1 		$46M Sell
1,329,800
-570,200
-30% -$15.5M 0.11% 239
2014
Q4 		$52M Buy
+1,900,000
New +$46.1M 0.13% 222

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners's DPLO Position: Q1 2017 in Review

Adage Capital Partners sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2017, closing a stake of 500,000 shares — an estimated $6.3M sold.

Adage Capital Partners first reported a position in DPLO in Q4 2014 and held it in 9 quarters. The position peaked at $52M in Q4 2014. 155 funds tracked by Wall St. Rank hold DPLO as of Q1 2017.

  • Adage Capital Partners reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2017 after selling out during the quarter.
  • Adage Capital Partners sold 500,000 DIPLOMAT PHARMACY, INC. shares in Q1 2017, an estimated $6.3M.
  • Adage Capital Partners first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 9 quarters.
  • Adage Capital Partners's DIPLOMAT PHARMACY, INC. position peaked at $52M in Q4 2014.
  • 155 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2017.

Based on Adage Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.